We sell in-depth short-selling reports for any company ₿ 0.10 BTC.
Contact us today.
Short PositionCAMX

Short Interest Shifts in Swedish Biotech and Energy

Recent regulatory disclosures from the Swedish Financial Supervisory Authority reveal notable shifts in short interest for Camurus AB and PowerCell Sweden AB.

Powered by NegativePublicRelations.com
By The Forensic Ledger DeskNovember 9, 20262 min read
Short Interest Shifts in Swedish Biotech and Energy

The Swedish market has seen active movement in public short positions as of early November 2026. D. E. Shaw has officially reduced its short position in the pharmaceutical firm Camurus AB to below the 0.5 percent threshold, signaling a potential retreat from its bearish stance. Despite this exit, total short interest in Camurus remains at approximately 4.46 percent of capital. Simultaneously, the fuel-cell developer PowerCell Sweden AB has attracted a new public short seller, with Citadel Securities disclosing a position above the 0.1 percent reporting requirement. These movements, tracked via the Swedish Financial Supervisory Authority, reflect the ongoing volatility in the Nordic small-cap space. For investors, the reduction of a position by a major player like D. E. Shaw in Camurus—coupled with a concurrent price target upgrade from Danske Bank—suggests a divergence in sentiment regarding the company's near-term valuation. Conversely, the entry of Citadel into PowerCell highlights the continued scrutiny of the hydrogen and fuel-cell sector, which remains a frequent target for short sellers due to high cash-burn rates and long-term commercialization risks. ## Sources - MarketScreener — Report on D. E. Shaw reducing its short position in Camurus, Nov 6, 2026. - MarketScreener — Report on Citadel Securities taking a short position in PowerCell, Nov 6, 2026.

Source

Original reporting by MarketScreener. This article is desk analysis prepared by The Forensic Ledger from publicly available sources, summarized with citation to the original.

#Short Selling#Sweden#Biotech#Energy

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets. Costs: ₿ 0.10 BTC

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog
Contact Us on Telegram